Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Declines By 62.5%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the recipient of a large decline in short interest during the month of May. As of May 29th, there was short interest totaling 6,057 shares, a decline of 62.5% from the May 14th total of 16,140 shares. Based on an average daily volume of 5,518 shares, the short-interest ratio is currently 1.1 days. Approximately 4.3% of the company’s shares are short sold.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

BIS stock traded down $0.06 during trading on Friday, hitting $16.80. The company had a trading volume of 4,228 shares, compared to its average volume of 8,198. The firm has a 50-day moving average price of $17.13 and a 200-day moving average price of $17.84. ProShares UltraShort Nasdaq Biotechnology has a 12 month low of $15.90 and a 12 month high of $36.80.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.